tiprankstipranks
Holding NOBL?
Track your performance easily

NOBL ETF Forecast & Price Targets

See the Price Targets and Ratings of:

NOBL Analyst Ratings

Moderate Buy
68ConsensusRatings
46 Buy
18 Hold
4 Sell
Based on the consensus analyst ratings on 68 stocks held in NOBL.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NOBL 12 Month Forecast

Average Price Target

$107.56
Based on 68 Wall Street analysts offering 12 month price targets to NOBL holdings in the last 3 months. The average price target is $107.56 with a high forecast of $121.77 and a low forecast of $92.52. The average price target represents a 9.77% change from the last price of $97.99.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"83":"$83","122":"$122","92.75":"$92.8","102.5":"$102.5","112.25":"$112.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":121.772,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$121.77</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":107.559,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$107.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":92.523,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$92.52</span>\n  </div></div>","useHTML":true}}],"tickPositions":[83,92.75,102.5,112.25,122],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,96.77,98.69323076923077,100.61646153846154,102.5396923076923,104.46292307692308,106.38615384615385,108.30938461538462,110.23261538461539,112.15584615384616,114.07907692307693,116.0023076923077,117.92553846153847,119.84876923076924,{"y":121.772,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,96.77,97.59992307692308,98.42984615384616,99.25976923076922,100.0896923076923,100.91961538461538,101.74953846153846,102.57946153846153,103.40938461538461,104.23930769230769,105.06923076923077,105.89915384615384,106.72907692307692,{"y":107.559,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,96.77,96.44330769230768,96.11661538461539,95.78992307692307,95.46323076923076,95.13653846153846,94.80984615384615,94.48315384615384,94.15646153846153,93.82976923076923,93.50307692307692,93.1763846153846,92.84969230769231,{"y":92.523,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":91.3,"date":1682899200000,"info":"<div>Price: <b>$91<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":86.54,"date":1685577600000,"info":"<div>Price: <b>$87<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":92.84,"date":1688342400000,"info":"<div>Price: <b>$93<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":95.03,"date":1690848000000,"info":"<div>Price: <b>$95<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":93.03,"date":1693526400000,"info":"<div>Price: <b>$93<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":86.68,"date":1696204800000,"info":"<div>Price: <b>$87<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":84.7,"date":1698796800000,"info":"<div>Price: <b>$85<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":91.16,"date":1701388800000,"info":"<div>Price: <b>$91<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":95.04,"date":1704153600000,"info":"<div>Price: <b>$95<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":95.31,"date":1706745600000,"info":"<div>Price: <b>$95<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":97.08,"date":1709251200000,"info":"<div>Price: <b>$97<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.68,"date":1711929600000,"info":"<div>Price: <b>$101<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":96.77,"date":1714521600000,"info":"<div>Price: <b>$97<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$121.77Average Price Target$107.56Lowest Price Target$92.52
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

NOBL Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
West Pharmaceutical Services, Inc.
2 Buy
0 Hold
0 Sell
Moderate Buy
$430.00
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Target Corp
20 Buy
9 Hold
0 Sell
Moderate Buy
$183.37
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Becton, Dickinson and Co
6 Buy
2 Hold
0 Sell
Strong Buy
$285.86
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Abbott Laboratories
9 Buy
1 Hold
0 Sell
Strong Buy
$127.70
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Nucor
3 Buy
4 Hold
0 Sell
Moderate Buy
$209.17

NOBL Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF
Please check back later or explore other ETFs for potential investment opportunities.

NOBL ETF FAQ

What is NOBL’s average 12-month price target, according to analysts?
Based on analyst ratings, NOBL’s 12-month average price target is $107.56.
    What is NOBL’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for NOBL, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is NOBL a Buy, Sell or Hold?
        NOBL has a consensus rating of Moderate Buy which is based on 46 buy ratings, 18 hold ratings and 4 sell ratings.
          What is NOBL’s price target?
          The average price target for NOBL is $107.56. This is based on 68 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $121.77 ,the lowest forecast is $92.52. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about NOBL?
            NOBL’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 68 Wall Streets Analysts.
              How can I buy shares of NOBL?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis